User profiles for L Schwamm
 | Lee Schwamm, MDProfessor of Neurology and Bioinformatics and Data Sciences, Yale School of Medicine Verified email at mgh.harvard.edu Cited by 145262 |
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 …
… , it had a mean total cholesterol level of 5.8 mmol/L (225 mg/dL). The government then … L
(182 mg/dL), and the prevalence of hypercholesterolemia (defined as cholesterol ≥6.5 mmol/L …
(182 mg/dL), and the prevalence of hypercholesterolemia (defined as cholesterol ≥6.5 mmol/L …
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart …
…, M Kelly-Hayes, EJ Kenton, M Marks, LH Schwamm… - Stroke, 2006 - Am Heart Assoc
… Normal fasting glucose is defined as glucose <100 mg/dL (5.6 mmol/L)… /L). A fasting plasma
glucose level >126 mg/dL (7.0 mmol/L) or a casual plasma glucose >200 mg/dL (11.1 mmol/L…
glucose level >126 mg/dL (7.0 mmol/L) or a casual plasma glucose >200 mg/dL (11.1 mmol/L…
Ischaemic stroke
Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart …
…, PH Mitchell, MW Rich, DJ Richardson, LH Schwamm… - Stroke, 2014 - Am Heart Assoc
The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association …
…, B Ovbiagele, YY Palesch, RL Sacco, LH Schwamm… - Stroke, 2011 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …
[HTML][HTML] A trial of imaging selection and endovascular treatment for ischemic stroke
…, BC Meyer, S Olson, LH Schwamm… - … England Journal of …, 2013 - Mass Medical Soc
Background Whether brain imaging can identify patients who are most likely to benefit from
therapies for acute ischemic stroke and whether endovascular thrombectomy improves …
therapies for acute ischemic stroke and whether endovascular thrombectomy improves …
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke
…, AF Hernandez, ED Peterson, LH Schwamm - Jama, 2013 - jamanetwork.com
Importance Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen
activator (tPA) in acute ischemic stroke is time dependent. However, modest sample …
activator (tPA) in acute ischemic stroke is time dependent. However, modest sample …
Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging.
…, FS Buonanno, RG Gonzalez, LH Schwamm… - Radiology, 1996 - pubs.rsna.org
PURPOSE: To evaluate acute stroke with conventional, multisection diffusion-weighted (DW),
and hemodynamically weighted (HW) magnetic resonance (MR) imaging. MATERIALS …
and hemodynamically weighted (HW) magnetic resonance (MR) imaging. MATERIALS …
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
…, EJ Kenton, M Marks, RL Sacco, LH Schwamm - Stroke, 2008 - Am Heart Assoc
analyses, which are subject to both type I and type II error, should be interpreted cautiously.
Initiation of study drug up to 5 years after the index event is significantly beyond the high-risk …
Initiation of study drug up to 5 years after the index event is significantly beyond the high-risk …
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association
Background and Purpose— Stroke mortality has been declining since the early 20th century.
The reasons for this are not completely understood, although the decline is welcome. As a …
The reasons for this are not completely understood, although the decline is welcome. As a …